Power Law company profile

Hua Medicine

Biotech & Life Sciences · Huangpu, China · Founded 2018 · IPO 2018 Colt

Leading clinical-stage, innovative drug development company in China

Valuation

$294M

Market cap · May/2026

Revenue

$68M

Latest reported FY

Featured in $1B+ revenueColt · Power Law growth-stage

Investors

13 investors on Hua Medicine's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage

F-Prime

ARCH Venture Partners

Venrock

WuXi Healthcare Ventures

Eight Roads Ventures

Series B+ 8 investors entered at this stage

WuXi AppTec

Blue Pool Capital

Ping An Ventures

Harvest Capital

Harvest Global Investments

Eight Roads Ventures China

Ally Bridge Group

Mirae Asset Venture Investment

Global footprint

Where Hua Medicine has talent and traffic

Workforce by country

🇨🇳 China · Huangpu HQ

Book a demo for the full country breakdown

Web traffic by country

1.1K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Market sentiment

What the market is saying about Hua Medicine

An AI-synthesized read of the highest-engagement posts about Hua Medicine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hua Medicine on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles